Patents by Inventor Jack Yoon

Jack Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED HEARTLAND VIRUS MRNA VACCINE
    Publication number: 20240189414
    Abstract: Provided herein are a Heartland virus vaccine composition including a messenger ribonucleic acid (mRNA) including an open reading frame (ORF) encoding Gn or Gc of Heartland virus, a Heartland virus vaccine composition comprising a messenger ribonucleic acid (mRNA) comprising an open reading frame (ORF) encoding Gn or Gc of Heartland virus fused with human collagen type I alpha 1 (COL1A1) signal peptide, and a method of inducing immune response against Heartland virus by administering an effective amount of the Heartland virus vaccine composition to a subject in need thereof.
    Type: Application
    Filed: December 6, 2023
    Publication date: June 13, 2024
    Applicants: Vernagen, LLC, The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Baek KIM, Jack Yoon, David Pak, Claire Yuhui Huang Kinney
  • Biopsy site marker for limited migration
    Patent number: 12004911
    Abstract: A biopsy site marker includes a carrier and a marker element. The marker element is disposed within the carrier. The carrier including a first marker material and a second marker material. The first marker material and the second marker material are each configured to expand in the presence of moisture. The first marker material is configured to expand at a rapid rate relative to the second marker material in the presence of moisture.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: June 11, 2024
    Assignee: Devicor Medical Products, Inc.
    Inventors: Elijah Kreider, Peter Shadix, Emmanuel V. Tanghal, Jordan Rebellino, Andrew Small, Ramon Alberto Ramos, Taylor Vohland, Jack A Randall, David C. McBreen, LeRonda Perry, Edward A. Rhad, Jessica P. Leimbach, Sarah Payne, Anne E. Storer, Andrew T. Robinson, John Kevin Bruce, Rachel Yoon Choung
  • ENGINEERED VARICELLA ZOSTER VIRUS SHINGLES MRNA VACCINE
    Publication number: 20240148861
    Abstract: Provided herein are a shingles vaccine composition including a messenger ribonucleic acid (mRNA) including an open reading frame (ORF) encoding varicella Zoster virus (VZV) glycoprotein E (gE)(which is soluble VZV gE or full-length VZV gE) and a method of inducing immune response against Shingles by administering an effective amount of the Shingles vaccine composition to a subject in need thereof.
    Type: Application
    Filed: November 8, 2023
    Publication date: May 9, 2024
    Applicant: Vernagen, LLC
    Inventors: Baek KIM, Jack Yoon, David Pak